FDA Clears J&J Oral Psoriasis Pill to Challenge Tremfya, Skyrizi
FDA approves J&J's oral psoriasis pill, setting up a direct challenge to injectable rivals Tremfya and Skyrizi and reshaping systemic options for plaque psoriasis.
Topic
Skyrizi
Topic
Topic
Topic
FDA approves J&J's oral psoriasis pill, setting up a direct challenge to injectable rivals Tremfya and Skyrizi and reshaping systemic options for plaque psoriasis.